Showing 1,661 - 1,680 results of 6,800 for search 'significantly ((((((less decrease) OR (we decrease))) OR (teer decrease))) OR (nn decrease))', query time: 0.58s Refine Results
  1. 1661

    GSConv working principle. by Pingping Yan (462509)

    Published 2025
    “…Furthermore, Parameters and GFLOPs were reduced by 10.0% and 23.2%, respectively, indicating a significant enhancement in detection accuracy along with a substantial decrease in both parameters and computational costs. …”
  2. 1662

    PR comparison on NWPU VHR-10 dataset. by Pingping Yan (462509)

    Published 2025
    “…Furthermore, Parameters and GFLOPs were reduced by 10.0% and 23.2%, respectively, indicating a significant enhancement in detection accuracy along with a substantial decrease in both parameters and computational costs. …”
  3. 1663
  4. 1664

    MiRNA primer sequences. by Hang Wu (5072618)

    Published 2024
    “…<div><p>Objective</p><p>In this experiment, we screened key miRNAs involved in the dexamethasone-induced decrease in osteogenic capacity of mouse precursor osteoblasts MC3T3-E1 over and investigated their specific regulatory mechanisms.…”
  5. 1665

    Osteogenesis-related primer sequences. by Hang Wu (5072618)

    Published 2024
    “…<div><p>Objective</p><p>In this experiment, we screened key miRNAs involved in the dexamethasone-induced decrease in osteogenic capacity of mouse precursor osteoblasts MC3T3-E1 over and investigated their specific regulatory mechanisms.…”
  6. 1666

    Adverse event list. by Stefan Halbherr (21353882)

    Published 2025
    “…No statistically significant improvements were seen in the Montreal Cognitive Assessment (MoCA) (mean decrease −0.73; 95% CI; −2.1, 0.62; <i>p</i> = 0.255), Epworth Sleepiness Scale (mean increase 0.09; 95% CI; −2.6, 2.8; <i>p</i> > 0.999), Beck Depression Inventory (BDI) (mean decrease −1.27; 95% CI; −3.8, 1.3; <i>p</i> = 0.257), and the Starkstein Apathy Scale (mean increase 0.36; 95% CI; −1.6, 2.4; <i>p</i> = 0.822). …”
  7. 1667

    Patient characteristics. by Stefan Halbherr (21353882)

    Published 2025
    “…No statistically significant improvements were seen in the Montreal Cognitive Assessment (MoCA) (mean decrease −0.73; 95% CI; −2.1, 0.62; <i>p</i> = 0.255), Epworth Sleepiness Scale (mean increase 0.09; 95% CI; −2.6, 2.8; <i>p</i> > 0.999), Beck Depression Inventory (BDI) (mean decrease −1.27; 95% CI; −3.8, 1.3; <i>p</i> = 0.257), and the Starkstein Apathy Scale (mean increase 0.36; 95% CI; −1.6, 2.4; <i>p</i> = 0.822). …”
  8. 1668

    Package alternatives for deli meat. by Monireh Mahmoudi (21989413)

    Published 2025
    “…To simulate opaque packaging conditions, we applied white duct tape externally to otherwise transparent packages. …”
  9. 1669

    The study timeline. by Monireh Mahmoudi (21989413)

    Published 2025
    “…To simulate opaque packaging conditions, we applied white duct tape externally to otherwise transparent packages. …”
  10. 1670

    The basic flowchart of analysis in this study. by Jing Wang (6206297)

    Published 2025
    “…Subsequently, in the single-cell analysis of AD peripheral blood, all hub-genes except SOD1 were found to be up-regulated in B cells, NK cells, and CD4+ T cells, possibly acting on the MIF pathway. Finally, we discovered that the levels of <i>PDK1</i> expression in AD patients were remarkably upregulated, while <i>FDX1</i> and <i>GLS</i> were significantly decreased using qPCR.…”
  11. 1671

    The enriched GO terms of the 19 DECAGs. by Jing Wang (6206297)

    Published 2025
    “…Subsequently, in the single-cell analysis of AD peripheral blood, all hub-genes except SOD1 were found to be up-regulated in B cells, NK cells, and CD4+ T cells, possibly acting on the MIF pathway. Finally, we discovered that the levels of <i>PDK1</i> expression in AD patients were remarkably upregulated, while <i>FDX1</i> and <i>GLS</i> were significantly decreased using qPCR.…”
  12. 1672

    Primers of the tested genes. by Jing Wang (6206297)

    Published 2025
    “…Subsequently, in the single-cell analysis of AD peripheral blood, all hub-genes except SOD1 were found to be up-regulated in B cells, NK cells, and CD4+ T cells, possibly acting on the MIF pathway. Finally, we discovered that the levels of <i>PDK1</i> expression in AD patients were remarkably upregulated, while <i>FDX1</i> and <i>GLS</i> were significantly decreased using qPCR.…”
  13. 1673

    Summary of patient demographic characteristics. by Jing Wang (6206297)

    Published 2025
    “…Subsequently, in the single-cell analysis of AD peripheral blood, all hub-genes except SOD1 were found to be up-regulated in B cells, NK cells, and CD4+ T cells, possibly acting on the MIF pathway. Finally, we discovered that the levels of <i>PDK1</i> expression in AD patients were remarkably upregulated, while <i>FDX1</i> and <i>GLS</i> were significantly decreased using qPCR.…”
  14. 1674

    S1 Dataset - by Edgar Innocent Guma (20370676)

    Published 2024
    “…<div><p>Interpersonal violence is a significant public health and human rights concern. …”
  15. 1675

    Detailed sequences of primers for PCR. by Jiangli Zhao (2308330)

    Published 2025
    “…N7-methylguanosine (m7G) is a prevalent RNA modification that has attracted significant attention in recent research. In this study, we investigated the regulatory pattern and clinical significance of m7G methylation in epilepsy. …”
  16. 1676

    Qualitative changes in the implant subgroup. by Adela Klezlova (22608008)

    Published 2025
    “…Eyes with the implant showed greater leukocyte infiltration and less type I collagen compared to the group without implants. …”
  17. 1677

    Results of the colorimetric MTT test. by Adela Klezlova (22608008)

    Published 2025
    “…Eyes with the implant showed greater leukocyte infiltration and less type I collagen compared to the group without implants. …”
  18. 1678

    IOP fluctuation. by Adela Klezlova (22608008)

    Published 2025
    “…Eyes with the implant showed greater leukocyte infiltration and less type I collagen compared to the group without implants. …”
  19. 1679

    IOP fluctuation. by Adela Klezlova (22608008)

    Published 2025
    “…Eyes with the implant showed greater leukocyte infiltration and less type I collagen compared to the group without implants. …”
  20. 1680

    Key safety measures including adverse events. by Anuja Dokras (8679261)

    Published 2025
    “…As there is a lack of robust evidence on the impact of these first-line medications on cardiovascular disease (CVD) risk, we compared the effect of COCPs, metformin or both on prevalence of metabolic syndrome (MetS) in participants with hyperandrogenic PCOS and hypothesized that COCPs would increase prevalence of MetS while metformin would decrease prevalence of MetS.…”